Kyprolis Drug Interactions: 324 Major, 232 Moderate
Kyprolis (Carfilzomib) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Kyprolis. Always confirm against the full prescribing information.
100 interactions
Abacavir
Abacavir may increase the hepatotoxic activities of Carfilzomib.
Level 2 evidence
Abiraterone
Abiraterone may increase the hepatotoxic activities of Carfilzomib.
Level 2 evidence
Acarbose
Acarbose may increase the hepatotoxic activities of Carfilzomib.
Level 2 evidence
Acetaminophen
Acetaminophen may increase the hepatotoxic activities of Carfilzomib.
Level 2 evidence
Acetazolamide
Acetazolamide may increase the hepatotoxic activities of Carfilzomib.
Level 2 evidence
Acitretin
Acitretin may increase the hepatotoxic activities of Carfilzomib.
Level 2 evidence
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Carfilzomib.
Level 2 evidence
Albendazole
Albendazole may increase the hepatotoxic activities of Carfilzomib.
Level 2 evidence
Allopurinol
The risk or severity of adverse effects can be increased when Allopurinol is combined with Carfilzomib.
Level 1 evidence
Ambrisentan
The serum concentration of Ambrisentan can be increased when it is combined with Carfilzomib.
Level 2 evidence
Aminosalicylic acid
Aminosalicylic acid may increase the hepatotoxic activities of Carfilzomib.
Level 2 evidence
Anidulafungin
Anidulafungin may increase the hepatotoxic activities of Carfilzomib.
Level 2 evidence
Enter your NPI to unlock 33 major interactions for Kyprolis
Kyprolis (Carfilzomib) has 857 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Kyprolis (Carfilzomib) has 324 major, 232 moderate, and 301 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Kyprolis. Always confirm against the full prescribing information.